Atlantic Health System Enrolls First U.S. Patient in Lupus Treatment Trial

NJ-based Atlantic Health System is the first in the U.S. to enroll a patient in a study to examine the effectiveness of using Chimeric Antigen Receptor (CAR- T)

Related Keywords

Thomas Jefferson University ,Pennsylvania ,United States ,New York ,Hackettstown ,New Jersey ,Pompton Plains ,Neil Kramer ,Atlantic Health System ,Hackettstown Medical Center ,Atlantic Alliance ,Atlantic Cellular Therapy Program ,Atlantic Health ,Morristown Medical Center ,Chilton Medical Center ,Atlantic Accountable Care Organization ,Newton Medical Center ,Atlantic Rehabilitation Institute In Madison ,Atlantic Mobile Health ,Institute For Rheumatic ,Atlantic Medical Group ,Sidney Kimmel Medical College At Morristown ,Cellular Therapy Program ,Healthcare Transformation Consortium ,Chimeric Antigen Receptor ,Targeted Next Chimeric Antigen Receptor ,Refractory Systemic Lupus Erythematosus ,Mohamad Cherry ,Medical Director ,Atlantic Cellular Therapy ,Autoimmune Diseases ,Overlook Medical ,Participants With Severe ,Health System ,Overlook Medical Center ,Goryeb Children ,Atlantic Rehabilitation Institute ,Centrastate Healthcare System ,Optimus Healthcare Partners ,Clinically Integrated Network ,Atlantic Visiting Nurse ,Atlantic Anywhere Virtual ,Atlantic Mobile ,Sidney Kimmel Medical College ,Overlook Medical Centers ,Newswise ,Art Cart Cell Lupus Autoimmune Disease Rheumatology ,Clinical Trials ,Healthcare ,Mmunology ,Lupus ,